GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Matrix protein
MATRX_VSIVA Reviewed; 229 AA.
P03519;
21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
21-JUL-1986, sequence version 1.
28-FEB-2018, entry version 94.
RecName: Full=Matrix protein;
Name=M;
Vesicular stomatitis Indiana virus (strain San Juan) (VSIV).
Viruses; ssRNA viruses; ssRNA negative-strand viruses;
Mononegavirales; Rhabdoviridae; Vesiculovirus.
NCBI_TaxID=11285;
NCBI_TaxID=7158; Aedes.
NCBI_TaxID=9913; Bos taurus (Bovine).
NCBI_TaxID=58271; Culicoides.
NCBI_TaxID=9793; Equus asinus (Donkey) (Equus africanus asinus).
NCBI_TaxID=9796; Equus caballus (Horse).
NCBI_TaxID=9606; Homo sapiens (Human).
NCBI_TaxID=252607; Lutzomyia.
NCBI_TaxID=7370; Musca domestica (House fly).
NCBI_TaxID=7190; Simuliidae (black flies).
NCBI_TaxID=9823; Sus scrofa (Pig).
[1]
NUCLEOTIDE SEQUENCE [GENOMIC RNA].
PubMed=6268840;
Rose J.K., Gallione C.J.;
"Nucleotide sequences of the mRNA's encoding the vesicular stomatitis
virus G and M proteins determined from cDNA clones containing the
complete coding regions.";
J. Virol. 39:519-528(1981).
[2]
SUBCELLULAR LOCATION.
PubMed=1850035;
Rigaut K.D., Birk D.E., Lenard J.;
"Intracellular distribution of input vesicular stomatitis virus
proteins after uncoating.";
J. Virol. 65:2622-2628(1991).
[3]
PHOSPHORYLATION.
STRAIN=Orsay;
PubMed=1323702;
Kaptur P.E., McCreedy B.J. Jr., Lyles D.S.;
"Sites of in vivo phosphorylation of vesicular stomatitis virus matrix
protein.";
J. Virol. 66:5384-5392(1992).
[4]
MUTAGENESIS OF MET-51.
PubMed=9733895;
Ahmed M., Lyles D.S.;
"Effect of vesicular stomatitis virus matrix protein on transcription
directed by host RNA polymerases I, II, and III.";
J. Virol. 72:8413-8419(1998).
[5]
INTERACTION WITH NUP98, AND MUTAGENESIS OF 5-LYS--ILE-7;
28-GLU--ASP-30; 42-ASP--SER-44; 52-ASP--TYR-54 AND 61-TYR--LYS-63.
PubMed=11106761; DOI=10.1016/S1097-2765(00)00120-9;
von Kobbe C., van Deursen J.M., Rodrigues J.P., Sitterlin D.,
Bachi A., Wu X., Wilm M., Carmo-Fonseca M., Izaurralde E.;
"Vesicular stomatitis virus matrix protein inhibits host cell gene
expression by targeting the nucleoporin Nup98.";
Mol. Cell 6:1243-1252(2000).
[6]
ALTERNATIVE INITIATION (ISOFORMS M2 AND M3).
PubMed=12134006; DOI=10.1128/JVI.76.16.8011-8018.2002;
Jayakar H.R., Whitt M.A.;
"Identification of two additional translation products from the matrix
(M) gene that contribute to vesicular stomatitis virus
cytopathology.";
J. Virol. 76:8011-8018(2002).
[7]
FUNCTION.
PubMed=16298982; DOI=10.1099/vir.0.81129-0;
Solon J., Gareil O., Bassereau P., Gaudin Y.;
"Membrane deformations induced by the matrix protein of vesicular
stomatitis virus in a minimal system.";
J. Gen. Virol. 86:3357-3363(2005).
[8]
FUNCTION, AND INTERACTION WITH HOST RAE1-NUP98 COMPLEX.
PubMed=15629720; DOI=10.1016/j.molcel.2004.11.023;
Faria P.A., Chakraborty P., Levay A., Barber G.N., Ezelle H.J.,
Enninga J., Arana C., van Deursen J., Fontoura B.M.;
"VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway.";
Mol. Cell 17:93-102(2005).
[9]
DOMAIN LATE-BUDDING.
PubMed=15220457; DOI=10.1128/JVI.78.14.7823-7827.2004;
Irie T., Licata J.M., Jayakar H.R., Whitt M.A., Bell P., Harty R.N.;
"Functional analysis of late-budding domain activity associated with
the PSAP motif within the vesicular stomatitis virus M protein.";
J. Virol. 78:7823-7827(2004).
[10]
CYTOPATHICITY.
PubMed=12692256; DOI=10.1128/JVI.77.9.5524-5528.2003;
Kopecky S.A., Lyles D.S.;
"The cell-rounding activity of the vesicular stomatitis virus matrix
protein is due to the induction of cell death.";
J. Virol. 77:5524-5528(2003).
[11]
DOMAIN LATE-BUDDING.
PubMed=16188963; DOI=10.1128/JVI.79.20.12617-12622.2005;
Irie T., Harty R.N.;
"L-domain flanking sequences are important for host interactions and
efficient budding of vesicular stomatitis virus recombinants.";
J. Virol. 79:12617-12622(2005).
[12]
MUTAGENESIS OF 121-ALA--ALA-124.
PubMed=16571787; DOI=10.1128/JVI.80.8.3701-3711.2006;
Connor J.H., McKenzie M.O., Lyles D.S.;
"Role of residues 121 to 124 of vesicular stomatitis virus matrix
protein in virus assembly and virus-host interaction.";
J. Virol. 80:3701-3711(2006).
[13]
FUNCTION, AND INTERACTION WITH HOST DYNAMIN.
PubMed=20943988; DOI=10.1128/JVI.01400-10;
Raux H., Obiang L., Richard N., Harper F., Blondel D., Gaudin Y.;
"The matrix protein of vesicular stomatitis virus binds dynamin for
efficient viral assembly.";
J. Virol. 84:12609-12618(2010).
[14]
INTERACTION WITH HOST NEDD4 AND TSG101, AND MUTAGENESIS OF LEU-4;
TYR-27 AND PRO-40.
STRAIN=Indiana (Orsay);
PubMed=22190013; DOI=10.1099/vir.0.039800-0;
Obiang L., Raux H., Ouldali M., Blondel D., Gaudin Y.;
"Phenotypes of vesicular stomatitis virus mutants with mutations in
the PSAP motif of the matrix protein.";
J. Gen. Virol. 93:857-865(2012).
-!- FUNCTION: Plays a major role in assembly and budding of virion, by
recruiting cellular partners of the ESCRT complexes that play a
key role in releasing the budding particle from the host membrane.
Condensates the ribonucleocapsid core during virus assembly.
{ECO:0000269|PubMed:16298982, ECO:0000269|PubMed:20943988}.
-!- FUNCTION: Shut off cellular protein expression by inhibiting mRNA
nuclear export through direct interaction with host RAE1-NUP98
complex. This shutoff presumably inhibits interferon signaling and
thus establishment of antiviral state in virus infected cells.
Induces cell-rounding, cytoskeleton disorganization and apoptosis
in infected cell. {ECO:0000269|PubMed:15629720}.
-!- SUBUNIT: Homomultimer. Interacts with viral nucleocapsid.
Interacts with host NEDD4 and TSG101 (PubMed:22190013). Interacts
with host dynamin (PubMed:20943988). Interacts with host RAE1-
NUP98 complex (PubMed:11106761, PubMed:15629720).
{ECO:0000269|PubMed:11106761, ECO:0000269|PubMed:15629720,
ECO:0000269|PubMed:20943988, ECO:0000269|PubMed:22190013}.
-!- SUBCELLULAR LOCATION: Virion membrane; Peripheral membrane protein
{ECO:0000269|PubMed:1850035}. Host endomembrane system; Peripheral
membrane protein. Host nucleus membrane; Peripheral membrane
protein.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative initiation; Named isoforms=3;
Name=M;
IsoId=P03519-1; Sequence=Displayed;
Name=M2 {ECO:0000303|PubMed:12134006};
IsoId=P03519-2; Sequence=VSP_025421;
Name=M3 {ECO:0000303|PubMed:12134006};
IsoId=P03519-3; Sequence=VSP_025420;
-!- DOMAIN: Late-budding domains (L domains) are short sequence motifs
essential for viral particle budding. They recruit proteins of the
host ESCRT machinery (Endosomal Sorting Complex Required for
Transport) or ESCRT-associated proteins. M contains two
overlapping L domains: a PPXY motif which interacts with the WW
domain 3 of NEDD4 and a PTAP/PSAP motif, which interacts with the
UEV domain of TSG101. {ECO:0000269|PubMed:15220457,
ECO:0000269|PubMed:16188963}.
-!- PTM: Phosphorylated by host. {ECO:0000269|PubMed:1323702}.
-!- BIOTECHNOLOGY: VSV is used as an oncolytic agent for cancer
therapy, because of his wide host range, rapid replication and
mild pathogenicity in humans. VSV used are mutated at M51R in
their matrix protein. These mutated viruses cannot successfully
infect normal cells, being unable to counteract the antiviral
state induced by interferon-alpha in normal cells. Cancer cells
are impeded with responsiveness to interferon, and then can be
successfully infected and lysed by the virus.
-!- MISCELLANEOUS: Most abundant protein in the virion.
-!- SIMILARITY: Belongs to the vesiculoviruses matrix protein family.
{ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; J02428; AAA48369.1; -; Genomic_RNA.
RefSeq; NP_041714.1; NC_001560.1.
ProteinModelPortal; P03519; -.
SMR; P03519; -.
ELM; P03519; -.
IntAct; P03519; 3.
MINT; P03519; -.
GeneID; 1489833; -.
KEGG; vg:1489833; -.
OrthoDB; VOG090000OM; -.
Proteomes; UP000002327; Genome.
GO; GO:0044200; C:host cell nuclear membrane; IEA:UniProtKB-SubCell.
GO; GO:0019031; C:viral envelope; IEA:InterPro.
GO; GO:0055036; C:virion membrane; IEA:UniProtKB-SubCell.
GO; GO:0039660; F:structural constituent of virion; IEA:UniProtKB-KW.
GO; GO:0016310; P:phosphorylation; IDA:UniProtKB.
GO; GO:0039657; P:suppression by virus of host gene expression; IEA:UniProtKB-KW.
GO; GO:0039522; P:suppression by virus of host mRNA export from nucleus; IDA:UniProtKB.
GO; GO:0039702; P:viral budding via host ESCRT complex; IDA:UniProtKB.
Gene3D; 3.10.460.10; -; 1.
InterPro; IPR009397; Vesiculo_matrix.
InterPro; IPR036711; VSV_matrix_sf.
Pfam; PF06326; Vesiculo_matrix; 1.
SUPFAM; SSF75404; SSF75404; 1.
1: Evidence at protein level;
Alternative initiation; Apoptosis; Complete proteome;
Eukaryotic host gene expression shutoff by virus;
Host gene expression shutoff by virus; Host membrane;
Host mRNA suppression by virus; Host nucleus; Host-virus interaction;
Inhibition of host mRNA nuclear export by virus; Membrane;
Phosphoprotein; Reference proteome; Viral budding;
Viral budding via the host ESCRT complexes; Viral matrix protein;
Viral release from host cell; Virion.
CHAIN 1 229 Matrix protein.
/FTId=PRO_0000222857.
MOTIF 2 4 dynamin binding.
{ECO:0000269|PubMed:20943988}.
MOTIF 24 27 PPXY motif.
MOTIF 37 40 PTAP/PSAP motif.
VAR_SEQ 1 50 Missing (in isoform M3). {ECO:0000305}.
/FTId=VSP_025420.
VAR_SEQ 1 32 Missing (in isoform M2). {ECO:0000305}.
/FTId=VSP_025421.
MUTAGEN 4 4 L->A: No effect on host NEDD4 or TSG101
binding. {ECO:0000269|PubMed:11106761}.
MUTAGEN 5 7 KKI->AAA: No effect on mRNA nuclear
export inhibition.
{ECO:0000269|PubMed:11106761}.
MUTAGEN 27 27 Y->A: Partial loss of host NEDD4 binding.
{ECO:0000269|PubMed:22190013}.
MUTAGEN 28 30 EED->AAA: No effect on mRNA nuclear
export inhibition.
{ECO:0000269|PubMed:11106761}.
MUTAGEN 40 40 P->A: Partial loss of host TSG101
binding. {ECO:0000269|PubMed:22190013}.
MUTAGEN 42 44 DKS->AAA: No effect on mRNA nuclear
export inhibition.
{ECO:0000269|PubMed:11106761}.
MUTAGEN 51 51 M->R: Complete loss of mRNA nuclear
export inhibition.
{ECO:0000269|PubMed:9733895}.
MUTAGEN 52 54 DTY->AAA: Complete loss of mRNA nuclear
export inhibition.
{ECO:0000269|PubMed:11106761}.
MUTAGEN 61 63 YEK->AAA: No effect on mRNA nuclear
export inhibition.
{ECO:0000269|PubMed:11106761}.
MUTAGEN 121 124 AVLA->DKQQ: No effect on virion budding.
Increase viral-mRNA translation.
{ECO:0000269|PubMed:16571787}.
SEQUENCE 229 AA; 26094 MW; C89E2ACA4365B847 CRC64;
MSSLKKILGL KGKGKKSKKL GIAPPPYEED TSMEYAPSAP IDKSYFGVDE MDTYDPNQLR
YEKFFFTVKM TVRSNRPFRT YSDVAAAVSH WDHMYIGMAG KRPFYKILAF LGSSNLKATP
AVLADQGQPE YHTHCEGRAY LPHRMGKTPP MLNVPEHFRR PFNIGLYKGT IELTMTIYDD
ESLEAAPMIW DHFNSSKFSD FREKALMFGL IVEKKASGAW VLDSISHFK
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Pathways :
WP1438: Influenza A virus infection
WP1032: NLR proteins
WP1049: G Protein Signaling Pathways
WP1060: Matrix Metalloproteinases
WP1071: Cytoplasmic Ribosomal Proteins
WP1165: G Protein Signaling Pathways
WP1176: Matrix Metalloproteinases
WP1187: Cytoplasmic Ribosomal Proteins
WP1239: Cytoplasmic Ribosomal Proteins
WP1256: NLR proteins
WP129: Matrix Metalloproteinases
WP1294: NLR proteins
WP1360: NLR proteins
WP1371: G Protein Signaling Pathways
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP163: Cytoplasmic Ribosomal Proteins
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
Related Genes :
[Mmp24 Mmp21 Mt5mmp] Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]
[MMP24 MT5MMP] Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]
[Mmp24 Mt5mmp] Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24]
[MMP23A MMP21; MMP23B MMP21 MMP22] Matrix metalloproteinase-23 (MMP-23) (EC 3.4.24.-) (Femalysin) (MIFR-1) (Matrix metalloproteinase-21) (MMP-21) (Matrix metalloproteinase-22) (MMP-22) [Cleaved into: Matrix metalloproteinase-23, soluble form]
[MMP9 CLG4B] Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]
[MMP14] Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP)
[MMP19 MMP18 RASI] Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18)
[MMP16 C8orf57 MMPX2] Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)
[Mmp14 Mtmmp] Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (MT-MMP) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP)
[MMP15] Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2)
[MMP17 MT4MMP] Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP)
[MMP25 MMP20 MMPL1 MT6MMP] Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP)
[Mmp17 Mt4mmp] Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP)
[Mmp14 Mtmmp] Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT-MMP) (MT1-MMP) (MT1MMP)
[Mmp16] Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)
[Mmp16] Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP)
[Ucma] Unique cartilage matrix-associated protein (Upper zone of growth plate and cartilage matrix associated protein) [Cleaved into: Unique cartilage matrix-associated protein C-terminal fragment (Ucma-C) (Gla-rich protein) (GRP)]
[Mmp23 Cammp] Matrix metalloproteinase-23 (MMP-23) (EC 3.4.24.-) (Cysteine array matrix metalloproteinase) (CA-MMP) (CAMP metalloproteinase) [Cleaved into: Matrix metalloproteinase-23, soluble form]
[MMP14] Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP)
[SRRM1 SRM160] Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein)
[MMP14] Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP)
[DMP1] Dentin matrix acidic phosphoprotein 1 (DMP-1) (Dentin matrix protein 1)
[Mmp19 Rasi] Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI)
[IMPG2 IPM200] Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa) (IPM 200) (Sialoprotein associated with cones and rods proteoglycan) (Spacrcan)
[IMPG1 IPM150 SPACR] Interphotoreceptor matrix proteoglycan 1 (Interphotoreceptor matrix proteoglycan of 150 kDa) (IPM-150) (Sialoprotein associated with cones and rods)
[SRRM2 KIAA0324 SRL300 SRM300 HSPC075] Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803)
[MMP14] Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP)
[Mmp23 Mifr] Matrix metalloproteinase-23 (MMP-23) (EC 3.4.24.-) (metalloprotease in the female reproductive tract) (MIFR) [Cleaved into: Matrix metalloproteinase-23, soluble form]
[DPT] Dermatopontin (22 kDa extracellular matrix protein) (Dermatan sulfate proteoglycan-associated protein 22K) (Tyrosine-rich acidic matrix protein) (TRAMP)
[MGP] Matrix Gla protein (MGP) [Cleaved into: Matrix Gla protein long form; Matrix Gla protein short form]
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits